ArticleOncotarget2015

Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.

Elisa Baldelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.